Valuation: HansBiomed Corporation

Market Cap 300B 221M 195M 185M 168M 314M 21.24B 317M 2.22B 854M 10.85B 831M 813M 34.9B P/E 2026 *
22.9x
P/E 2027 * 11.8x
Enterprise Value 331M 244K 215K 204K 185K 346K 23.39M 349K 2.44M 941K 11.94M 915K 895K 38.44M EV / Sales 2026 *
2.33x
EV / Sales 2027 * 1.47x
Free-Float
64.21%
Yield 2026 *
-
Yield 2027 * -
1 day+16.88%
1 week+21.54%
Current month+3.19%
1 month+6.10%
3 months-17.29%
6 months-48.78%
Current year-23.73%
1 week 17,800
Extreme 17800
21,400
1 month 17,320
Extreme 17320
21,700
Current year 15,300
Extreme 15300
57,800
1 year 15,300
Extreme 15300
57,800
3 years 6,180
Extreme 6180
57,800
5 years 6,180
Extreme 6180
57,800
10 years 6,180
Extreme 6180
57,800
Manager TitleAgeSince
Chief Executive Officer 62 2018-11-30
Sales & Marketing 47 -
Comptroller/Controller/Auditor 60 2017-12-05
Director TitleAgeSince
Director/Board Member 67 1999-08-31
Director/Board Member 62 2018-11-30
Director/Board Member 56 2019-12-25
Date Insider Type Main position Quantity % Market Cap. Importance
1/7/25 Others 2,500 0.0185%
Change 5-day change 1-year change 3-year change Capi.($)
+16.88%+21.54%+34.59%+17.40% 221M
+1.26%+1.34%-24.63%+2.01% 107B
+0.74%+1.24%-23.74%+2.25% 11.24B
-0.01%-0.82%+95.07%+110.70% 9.35B
+0.33%-1.52%-49.54%-67.02% 4.13B
-1.79%-0.02%-24.09%+24.68% 2.44B
+4.54%+2.64%-3.21%-63.12% 2.12B
-0.20%-4.27% - - 1.9B
-0.58%-2.03%-22.53%-32.61% 1.51B
Average +2.18%+1.36%-2.26%-0.71% 15.54B
Weighted average by Cap. -0.09%+0.77%-16.74%+6.38%

Financials

2026 *2027 *
Net sales 142B 104M 92.2M 87.24M 79.11M 148M 10.03B 150M 1.05B 403M 5.12B 392M 384M 16.47B 202B 149M 131M 124M 113M 211M 14.26B 213M 1.49B 574M 7.28B 558M 546M 23.43B
Net income 13B 9.58M 8.46M 8M 7.26M 13.61M 920M 13.74M 96.01M 37M 470M 35.99M 35.21M 1.51B 25.4B 18.73M 16.53M 15.64M 14.18M 26.59M 1.8B 26.85M 188M 72.3M 918M 70.32M 68.79M 2.95B
Net Debt 30.4B 22.41M 19.78M 18.72M 16.97M 31.82M 2.15B 32.14M 225M 86.53M 1.1B 84.16M 82.33M 3.53B -3B -2.21M -1.95M -1.85M -1.67M -3.14M -212M -3.17M -22.16M -8.54M -108M -8.31M -8.13M -349M
Logo HansBiomed Corporation
Hans Biomed Corp is a Korea-based company primarily engaged in the biotechnology industry. The Company is mainly engaged in the medical devices business, including skin and bone grafts for human transplantation, facial tissue fixation sutures, and silicone products. In addition, the Company is engaged in the provision and sale of medical devices, bone grafts, skin grafts, and silicone products.
Employees
315
Date Price Change Volume
26-09-29 ₩21,050.00 +16.88% 252,606
26-09-28 ₩18,010.00 +1.29% 73,909
26-09-23 ₩17,780.00 +2.66% 66,408
26-09-22 ₩17,320.00 -2.26% 94,081
Trader
Investor
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A042520 Stock